Antibody to Bevacizumab ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Bevacizumab (Avastin®) in serum and plasma.

The solid phase (MTP) is coated by the drug Bevacizumab. Due to the assay design this test only measures the free antibodies which are not bound to Bevacizumab. Results are expressed in AU (arbitrary units).

Reference: IG-BB104

Barcode: 8682754930141

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

ig-bb104

Related Documents


Quality Control Certificates

 

Avastin® is a trademark of Genentech Inc./Roche.

The Kit at a glance:

ig-bb104

Required Volume (µL) 10
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Shelf Life (years) 2